The Army recently inked a $3.5 billion contract with Pfizer Inc. for the pharmaceutical company to produce 500 million doses of its COVID-19 vaccine.
But those shots are not planned for soldiers’ shoulders.
Instead, the contract award states, they are for “international donation” and procurement is expected to be completed by Dec. 31, 2022, according to the Pentagon.